Nivo + ipi in unresectable stage III/IV melanoma
Michael Postow, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, USA, talks through data from a phase II…
Michael Postow, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, USA, talks through data from a phase II…
In this week’s podcast by VJ Oncology, six leading experts share their insights on cutting-edge developments in colorectal cancer screening…
Debjani Pal, PhD, Oak Ridge National Laboratory, Oak Ridge, TN, discusses the emergence of targeted radionuclide therapy (TRT) for personalized cancer treatment by delivering radiation…
Elizabeth Swisher, MD, University of Washington in Seattle, WA, discusses the MAGENTA (Making Genetic Testing Accessible) trial (NCT02993068), which aimed to make genetic testing more…
Pasi Jänne, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses results from an exploratory analysis of EGFR mutation (EGFRm) dynamics in the Phase III FLAURA2…
Pasi Jänne, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses results from an exploratory analysis of EGFR mutation (EGFRm) dynamics in the Phase III FLAURA2…
Scott Kopetz, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses findings from an analysis of the Phase I and II…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Mitchell Elliott, MD, UHN Princess Margaret Cancer Centre, Toronto, Canada, discusses the preclinical evaluation of ARB-1-6, a sortilin (SORT1) targeted peptide conjugated to MMAE, in…
Sebastian Klobuch, PhD, Netherlands Cancer Institute, Amsterdam, The Netherlands, discusses advances in tumor-infiltrating lymphocytes (TILs) and T cell receptor (TCR) modified cell therapy in oncology.…
Ben Tran, MBBS, FACP, Peter MacCallum Cancer Centre, Melbourne, Australia, provides a horizon scan in the testicular cancer field. In patients who are cisplatin resistant,…